5 completed, 1 recruiting, 1 terminated. 3 Phase 3, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Mylan Laboratories: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANRS 12372 MODERATO Study dolutegravir, atazanavir boosted with ritonavir, tenofovir + lamivudine +efavirenz or dolutegravir + lamivudine + tenofovir - HIV-1-infection | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 480 | 2020-11-17 | 2026-10-16 |
| COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) cholecalciferol 200,000 IU, cholecalciferol 50,000 IU - Coronavirus | Phase 3 | Completed | University Hospital, Angers | 260 | 2020-04-15 | 2021-04-30 |
| PrEP Demonstration Study in Swaziland PrEP Promotion Package - HIV Negative People Identified at Substantial Risk for HIV Infection | Not applicable | Completed | Clinton Health Access Initiative Inc. | 517 | 2017-08-01 | 2019-07-11 |
| Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz generic FDC of TDF/3TC/EFV - HIV | Phase 2 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 100 | 2010-06-01 | 2020-07-17 |
| Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension Metoprolol ER, Nebivolol - Hypertension | Phase 3 | Terminated | Forest Laboratories | 49 | 2007-10-31 | 2019-05-21 |
| Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. HIV Infections, Hepatitis B | Recruiting | Syneos Health | 24258 | 1989-01-01 | 2025-04-01 | |
| A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease Cysteamine, Zidovudine - HIV Infections | Phase 2 | Completed | Mylan Laboratories | 300 | 2005-06-24 |
HIV Infections (2) · AIDS-Related Complex (1) · Coronavirus Infections (1) · Hepatitis (1) · Hepatitis B (1) · Hypertension (1)
Cholecalciferol (1) · Cysteamine (1) · Lamivudine (1) · Metoprolol (1) · Nebivolol (1) · Ritonavir (1) · Tenofovir (1) · Zidovudine (1) · dolutegravir (1)
United States (3) · Burkina Faso (1) · Cameroon (1) · Côte d’Ivoire (1) · Eswatini (1) · France (1) · Thailand (1)
Anchalee Avihingsanon, MD, PhD (1) · Jessica D Albano, PhD, MPH (1) · Pierre-Marie Girard, MD, PhD (1) · Roland Landman, MD (1) · Sindy Matse, MPH (1) · Xavier Anglaret, MD, PhD (1)
PMID 26269220, PMID 26687320, PMID 33371905, PMID 33757717, PMID 35639792